HomeCRVS • NASDAQ
add
Corvus Pharmaceuticals Inc
Previous close
$5.91
Day range
$5.31 - $6.05
Year range
$1.05 - $6.15
Market cap
340.28M USD
Avg Volume
496.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.94M | 5.57% |
Net income | -4.26M | 34.46% |
Net profit margin | — | — |
Earnings per share | -0.07 | 50.00% |
EBITDA | -5.91M | -5.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 47.25M | 27.63% |
Total assets | 64.56M | 11.23% |
Total liabilities | 13.34M | 55.82% |
Total equity | 51.23M | — |
Shares outstanding | 62.55M | — |
Price to book | 7.21 | — |
Return on assets | -28.36% | — |
Return on capital | -34.37% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -4.26M | 34.46% |
Cash from operations | -5.48M | -4.94% |
Cash from investing | -17.50M | -308.11% |
Cash from financing | 30.37M | 304.07% |
Net change in cash | 7.38M | 469.99% |
Free cash flow | 3.75M | 216.41% |
About
Founded
2014
Headquarters
Website
Employees
28